A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RECRUITING

St Vincent's Hospital, Darlinghurst

RECRUITING

Linear Clinical Research, Nedlands

RECRUITING

Catalan Institute of Oncology Duran i Reynals Hospital, Barcelona

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

RECRUITING

Hospital Madrid Norte Sanchinarro, Madrid

RECRUITING

Florida Cancer Specialists and Research Institute, St. Petersburg

RECRUITING

Sarah Cannon Research Institute, Nashville

RECRUITING

Hospital Universitario Virgen Del Rocio, Seville

RECRUITING

START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids

RECRUITING

University of Chicago Hospital, Chicago

RECRUITING

South Texas Accelerated Research Therapeutics (START), San Antonio

RECRUITING

Sarah Cannon Research Institute at HealthOne, Denver

RECRUITING

University of Utah - Huntsman Cancer Institute, Salt Lake City

RECRUITING

START Mountain Region, West Valley City

RECRUITING

Institut Gustave Roussy (Igr), Villejuif

RECRUITING

City of Hope National Medical Center, Duarte

RECRUITING

Massachusetts General Hospital, Boston

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

RECRUITING

Columbia University Irving Medical Center, New York

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

RECRUITING

The Cancer Institute Hospital of JFCR, Kōtō City

RECRUITING

Aichi Cancer Center Hospital, Nagoya

RECRUITING

Asan Medical Center, Seoul

RECRUITING

St Bartholomew's Hospital, London

RECRUITING

The Christie NHS Foundation Trust, Manchester